Polynovo Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
60.20
22.30
3,277.20
3,620.10
5,714.50
Cost of Goods Sold (COGS) incl. D&A
-
-
-
3,565.40
6,471.10
Gross Income
-
-
-
54.70
756.60
SG&A Expense
3,954.80
3,766.70
7,430.50
6,032.80
6,332.20
EBIT
4,109.80
3,949.50
4,373.00
5,978.10
7,088.80
Unusual Expense
-
26.30
-
-
-
Non Operating Income/Expense
24.20
1,623.90
80.90
-
-
Pretax Income
3,901.20
2,233.60
4,098.70
5,839.20
6,813.50
Income Tax
959.20
819.30
846.80
833.20
839.40
Consolidated Net Income
2,942.00
1,414.30
3,251.80
5,006.00
5,974.10
Net Income
2,936.40
1,302.40
3,061.90
5,006.00
5,974.10
Net Income After Extraordinaries
2,936.40
1,302.40
3,061.90
5,006.00
5,974.10
Net Income Available to Common
2,936.40
1,302.40
3,061.90
5,006.00
5,974.10
EPS (Basic)
0.01
0.00
0.01
0.01
0.01
Basic Shares Outstanding
410,941.50
418,509.40
493,258.20
561,760.30
627,887.10
EPS (Diluted)
0.01
0.00
0.01
0.01
0.01
Diluted Shares Outstanding
410,941.50
418,509.40
493,258.20
561,760.30
627,887.10
EBITDA
3,894.60
3,744.40
4,153.30
5,731.10
6,545.90
Non-Operating Interest Income
184.40
118.40
193.40
138.90
275.30
Minority Interest Expense
5.60
111.90
190.00
-
-

About Polynovo

View Profile
Address
320 Lorimer Street
Port Melbourne Victoria (VIC) 3207
Australia
Employees -
Website http://polynovo.com.au
Updated 07/08/2019
Polynovo Ltd. operates as a biotechnology company. It designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The company's products are NovoPore is used as a dressing in negative pressure wound therapy and Biodegradable Temporising Matrix is a wound dressing intended for treatment of full-thickness wounds.